# Tight control for Crohn’s disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial

> Research article (Gut, 2019) · cited 35× · AI/ML

**Wikidata**: [openalex:W2960398624](https://www.wikidata.org/wiki/openalex:W2960398624)  
**Source**: https://4ort.xyz/entity/tight-control-for-crohns-disease-with-adalimumab-based-treatment-is-cost-effective-an-economic-assessment-of-the-calm-tr